Medical Communications

Neuronetics, Inc and Chris Thatcher, the President and CEO, have mutually agreed that he will step down from his positions …

Big pharma has been hit by the coronavirus (COVID-19) outbreak right on its doorstep, as two of the biggest names …

The American College of Cardiology has cancelled its upcoming ACC.20 event with the World Congress of Cardiology due to concerns …

Pharmacovigilance is a critical function in ensuring public health, but is our current system built to tackle the challenges of …

The coronavirus continues to threaten the global drug supply line, with disruption to the US drug production pipeline from the …

Chimeric antigen receptor T cell (CAR-T) therapy has gained much traction and attention in the past years for its innovative …

A cross-party group of MPs have said that those with HIV do not have access to adequate mental health treatment. …

New Phase 3 has been released by AstraZeneca, showing that the PD-L1 inhibitor Imfinzi (durvalumab), when combined with tremelimumab, failed …

The Drug Controller General of India (DCGI) has approved the marketing application for Zydus Cadila’s saroglitazar to treat patients with …

This article was originally published in the January/February 2020 issue of Pharmafocus.With the advent of a New Year, Michael Jewell, …

Takeda’s subcutaneous formulation of its gut-selective biologic vedolizumab has secured recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal …

The coronavirus continues to spread across the globe as the US launch their first trials for Gilead’s ebola drug remdesivir …

UK-based Acacia Pharma has secured its first US approval with the FDA’s decision to authorise Barhemsys (amisulpride injection) for the …

A person has been diagnosed with coronavirus in Wales, with the number of infected continuing to rise as numerous sporting …

A type of E. coli infection may increase a person’s chance of developing bowel cancer, according to a new study …